PharmaSGP Holding SE (XTER:PSG) Total Equity : €36.9 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Total Equity?

PharmaSGP Holding SE's total equity for the quarter that ended in Sep. 2024 was €36.9 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PharmaSGP Holding SE Total Equity Historical Data

The historical data trend for PharmaSGP Holding SE's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Total Equity Chart

PharmaSGP Holding SE Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

95.58

11.51

22.20

31.10

39.75

PharmaSGP Holding SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Equity	Get a 7-Day Free Trial															36.58	39.75	44.67	32.61	36.95

PharmaSGP Holding SE Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PharmaSGP Holding SE's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	131.299	-	91.545
	=	39.8

PharmaSGP Holding SE's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2024 )	-	Total Liabilities(Q: Sep. 2024 )
	=	129.516	-	92.568
	=	36.9

PharmaSGP Holding SE Total Equity Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaSGP Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166

Website

https://www.sgp-pharma.com

PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.

Executives

Dr. Clemens Fischer	Supervisory Board
Madlena Hohlefelder	Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines